Focus on patient experience can improve diabetes care.

Position statement reflects consensus of medical organizations and patient advocates
Position statement reflects consensus of medical organizations and patient advocates

Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate the attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.



The position statement reflects the consensus of two virtual roundtables the Endocrine Society held in 2022. Participants included representatives from the American College of Cardiology, American College of Physicians, American Diabetes Association®, Association of Diabetes Care & Education Specialists, Diabetes Technology Society, the U.S. Centers for Disease Control and Prevention, diabetes research organization dQ&A, and patient advocacy organizations DiabetesSisters, Close Concerns, and Taking Control of Your Diabetes.



More than 500 million people worldwide have diabetes, which occurs when the pancreas doesn’t make enough insulin or when the body can’t respond to insulin properly, resulting in high levels of glucose in the blood (blood glucose). Managing this chronic disease requires making lifestyle changes throughout life, which can be burdensome for people living with diabetes and their caregivers. Daily tasks such as blood glucose monitoring, dietary and exercise management, routine preventive care scheduling, and medication management must be overseen by people living with diabetes themselves.

Effective two-way communication between people with diabetes and their healthcare providers helps establish a shared understanding of the treatment plan and goals. Healthcare providers who take the time to explain treatment options and discuss potential barriers can improve patient satisfaction and clinical outcomes. In addition, healthcare providers need to consider each patient’s level of health literacy and cultural background when discussing treatment options.

“Many existing educational resources are available to help health care providers think through ways they can discuss diabetes treatment in a neutral and nonjudgmental way and practice using those strategies,” said Rita R. Kalyani, M.D., M.H.S., Professor of Medicine in the Division of Endocrinology, Diabetes, & Metabolism at Johns Hopkins University School of Medicine, who chaired the position statement and represented the Endocrine Society during the consensus roundtables. “However, in the ever-changing landscape of diabetes and its management, both health care providers and people with diabetes will continue to need new and evolving tools to help address the common challenges they face.”

People with diabetes face an elevated risk of developing depression, anxiety, and other mental disorders. This makes understanding the psychosocial impact of diabetes important. Addressing stressors in the health care setting and ensuring timely mental health referrals, when appropriate, can help individuals with diabetes feel more comfortable and help them participate more fully in their appointments and care.

Each section in the position statement begins with a common clinical scenario that illustrates key gaps in diabetes care. Readily accessible graphics and tools that health care providers can use to deliver patient-centred care are also included.

The position statement offers a framework for leveraging the experiences of people with diabetes to optimize health outcomes in several important areas, including:

  • Use of person-centred language in the health care setting
  • Ensuring referrals to diabetes self-management and support service programs are timely and accessible to all people with diabetes.
  • Effectively navigating available therapeutic options together and explaining complex regimens to people with diabetes to encourage them to take medication as prescribed.
  • Consider ways to adjust an individual’s treatment plan promptly if they aren’t meeting therapeutic goals to prevent therapeutic inertia.
  • Discussing strategies for assessment of hypoglycemia—low blood glucose episodes that can be dangerous—as well as prevention and treatment of hypoglycemia.
  • Improving cardiovascular and renal outcomes using newer therapeutic options.
  • Using telehealth in the appropriate clinical setting.
  • Using and incorporating diabetes technologies such as insulin pumps and continuous glucose monitoring systems into the diabetes management plan, when appropriate.